Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin in recent ischemic stroke
KCT0003890Phase 4Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ezetimibe in ischemic stroke, hypercholesterolemia, sponsored by Hanmi Pharmaceutical. Started Sep 2019; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
ischemic strokehypercholesterolemia
Beyond the preview
Go deeper on KCT0003890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003890.